Chemed (CHE) PT Raised to $609 at RBC Capital
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts CHE Hot Sheet
Price: $548.64 +2.81%
Rating Summary:
3 Buy, 4 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 17 | Down: 29 | New: 13
Rating Summary:
3 Buy, 4 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 17 | Down: 29 | New: 13
Join SI Premium – FREE
RBC Capital analyst Frank Morgan raised the price target on Chemed (NYSE: CHE) to $609.00 (from $604.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Chemed Corporation to Present at the UBS 2026 Global Healthcare Conference
- Datadog (DDOG) PT Lowered to $245 at Stifel
- GlobalFoundries Inc. (GFS) PT Lowered to $50 at Jefferies
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
